Rsm Us Wealth Management »

Halozyme Therapeutics shares owned by Rsm Us Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Rsm Us Wealth Management from 13F filings

Historical chart of Rsm Us Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Rsm Us Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Rsm Us Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $32k 28k 1.14
2025-06-30 $28k 28k 0.99
2025-03-31 $30k 28k 1.06
2024-12-31 $45k 47k 0.95
2024-09-30 $47k 47k 1.00
2024-06-30 $27k 28k 0.95

More positions owned by Rsm Us Wealth Management

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Bank of America Corporation (BAC)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)

View all positions for Rsm Us Wealth Management

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
MacKay Shields
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
Calamos Advisors
Wellesley Investment Advisors
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation

View all funds holding Halozyme Therapeutics